Results
1
Companies which are potentially undervalued and in an acceptable financial position.
1 companies
Hypera
Market Cap: R$14.6b
Operates as a pharmaceutical company in Brazil.
HYPE3
R$20.70
7D
-1.8%
1Y
-24.7%